Galapagos NV (Galapagos NV) Total Stockholders Equity : $3,048.6 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Galapagos NV Total Stockholders Equity?

Galapagos NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $3,048.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Galapagos NV's Book Value per Share for the quarter that ended in Dec. 2023 was $46.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Galapagos NV's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Galapagos NV Total Stockholders Equity Historical Data

The historical data trend for Galapagos NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Total Stockholders Equity Chart

Galapagos NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3,195.18

3,248.61

2,986.85

2,675.88

3,048.60

Galapagos NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															2,675.88	2,745.83	2,799.51	2,797.82	3,048.60

Galapagos NV (OTCPK:GLPGF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Galapagos NV's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3048.6	-	0)	/	65.8971
	=	46.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Galapagos NV's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.073	+	5.391)	/	3048.6
	=	0.00

Galapagos NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV (Galapagos NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (OTCPK:GLPGF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

GLPG:USA GLPG:Netherlands GLPG:Mexico 0JXZ:UK GXE:Germany GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.